Network origin in Omid Karkouti first degree
Entity | Entity type | Industry | |
---|---|---|---|
Rarebase, PBC
Rarebase, PBC Packaged SoftwareTechnology Services Rarebase, PBC is a biotech company that is dedicated to discovering and developing medicines for rare diseases. The company is based in Palo Alto, CA and was founded by Onno Faber and Omid Karkouti. The company has a product engine that is designed to discover treatments for hundreds of monogenic diseases simultaneously. Rarebase has already uncovered potential treatments for hundreds of rare diseases and has built a "drug-gene atlas" to enable AI-driven drug discovery. Onno Faber has been the CEO since incorporation.
4
| Holding Company | Packaged Software | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Omid Karkouti via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Inova Health System Services
Inova Health System Services Hospital/Nursing ManagementHealth Services Inova Health System provides health care services. It operates a network of hospitals, nursing homes, assisted living facilities, outpatient services and facilities, primary and specialty care physician practices, emergency and urgent care centers, home health care, mental health and blood donor services, wellness classes, and more. The company was founded in 1956 and is headquartered in Falls Church, VA. | Hospital/Nursing Management | Private Equity Investor | |
KaloCyte, Inc.
KaloCyte, Inc. BiotechnologyHealth Technology Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD. | Biotechnology | Director/Board Member | |
Thymmune Therapeutics
Thymmune Therapeutics BiotechnologyHealth Technology Thymmune Therapeutics is a preclinical biotechnology company located in the US that is developing a machine learning-enabled thymic cell engineering platform to restore normal immune function in aging and disease. The American company's approach in ipsc-thymic cell manufacturing can generate off-the-shelf cells at scale. Thymmune is developing a pipeline of therapies to treat immunodeficiencies, transplant-related, and autoimmune diseases. The company has strong IP positioning and is backed by early investors and founders of successful high-profile biotechnology companies. | Biotechnology | Director/Board Member | |
Boston University | College/University | Graduate Degree | |
College of Charleston | College/University | Undergraduate Degree | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Investment Managers | Private Equity Investor | |
Aronora, Inc.
Aronora, Inc. Pharmaceuticals: MajorHealth Technology Aronora, Inc. operates as an early clinical stage translational biopharmaceutical company. It researches and develops proprietary biological therapeutics. The company was founded by Andras Gruber and Erik I. Tucker and is headquartered in Portland, OR. | Pharmaceuticals: Major | Director/Board Member | |
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services New York Blood Center, Inc. operates blood distribution and research organizations. It provides blood and blood products for transfusions annually. The company was founded in 1964 and is located in New York, NY. | Medical/Nursing Services | Private Equity Investor | |
Nybc Ventures
Nybc Ventures Investment ManagersFinance NYBC Ventures (NYBC Ventures) is a venture capital subsidiary of New York Blood Center Inc founded in 2022. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Lehigh University | College/University | Undergraduate Degree | |
AllStripes Research, Inc.
AllStripes Research, Inc. Packaged SoftwareTechnology Services AllStripes Research, Inc. engages in the provision of drug development services. It offers patients and families to get access to and benefit from their own medical data. The company was founded by Onno Faber and Nancy Yu and is headquartered in San Francisco, CA. | Packaged Software | Founder | |
Georgetown University | College/University | Graduate Degree | |
The Global Good Fund
The Global Good Fund Miscellaneous Commercial ServicesCommercial Services The Global Good Fund is a non-profit social impact accelerator that invests in people to ignite positive impact and lasting social change. The private company is based in Washington. The organization offers fellowship and other nonprofit programs that strengthen the leadership capacity of innovators who are focused on solving complex issues. The Global Good Fund has supported over 200 entrepreneurs across 40 countries, creating 3,000+ permanent jobs and effecting positive change for more than 10,000,0000 people around the world. The organization also provides customized small business coaching and technical assistance, leadership development programs, and advisory services for other organizations through its consulting practice. The Global Good Fund's sister organization, the Impact Fund, is a venture capital fund that invests in mission-driven companies, with a focus on those led by people of color and women. The American company was founded by Carrie Rich. Carrie Rich has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
Cabinet Health, Inc.
Cabinet Health, Inc. Pharmaceuticals: MajorHealth Technology Cabinet Health, Inc. is an American sustainable healthcare company that offers healthcare products and services. The company is based in Washington. Cabinet Health is an online pharmacy that provides medicines for various health issues such as cold, upset stomach, and more. The company was founded by Russell Gong and Achal Patel in 2018 with a vision to revolutionize the way the industry packages and fills every type of medicine. Achal Patel has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Global Impact Funds Management SARL | Private Equity Investor | ||
Rezon8 Capital & Advisory Group LLC
Rezon8 Capital & Advisory Group LLC Investment ManagersFinance Rezon8 Capital & Advisory Group LLC (Rezon8 Capital & Advisory Group) is a private equity firm founded in 2011 by K. Paul Singh. The firm is headquartered in Reston, Virginia. | Investment Managers | Consultant / Advisor | |
Trinity Health Corp.
Trinity Health Corp. Miscellaneous Commercial ServicesCommercial Services Trinity Health Corp. engages in the provision of healthcare services. It offers health volunteers, cancer network, senior services management, integrity and compliance, and population health and supply chain management solutions. The firm operates hospitals, home health agencies, and hospice programs. The company was founded on May 1, 2013 and is headquartered in Livonia, MI. | Miscellaneous Commercial Services | Director/Board Member | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Stony Brook University | College/University | Doctorate Degree | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
Catena Biosciences, Inc.
Catena Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
United States | 24 |
Luxembourg | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 7 |
Finance | 5 |
Commercial Services | 4 |
Technology Services | 3 |
Operational
Director/Board Member | 6 |
Private Equity Investor | 6 |
Chief Executive Officer | 4 |
Founder | 4 |
Undergraduate Degree | 3 |
Most connected contacts
Insiders | |
---|---|
Meg Wood | 11 |
Carrie Rich | 9 |
Christopher Moxham | 5 |
Onno Faber | 3 |
- Stock Market
- Insiders
- Omid Karkouti
- Company connections